Skip to main content
. 2016 Jan 31;2016:2428052. doi: 10.1155/2016/2428052

Table 1.

Measurements of heart morphometric.

Parameters Control (—) OVX 5 OVX 9 Treatment I Treatment II Treatment III ANOVA
BW (gram) 236.5 ± 14.2 280.8 ± 33.4 264.3 ± 20.0 237.0 ± 19.9 250.8 ± 16.5 252.5 ± 34.6 0.124
LVW (mg) 501 ± 16.2 578.8 ± 54.6# 547 ± 41.6 502.6 ± 25.1 519.2 ± 40.3 514.5 ± 30.8 0.026∗∗
RVW (mg) 127 ± 15.6 136.6 ± 22.0 119.7 ± 16.9 125.4 ± 24.9 121.8 ± 16.9 119.3 ± 8.3 0.706
AW (mg) 82.9 ± 3.4 88.9 ± 10.0 81.5 ± 5.05 88.8 ± 2.9 84.4 ± 5.5 80.3 ± 1.7 0.174
LVW/HW ratio 0.705 0.720 0.731 0.704 0.716 0.720 0.298
HW/BW ratio 3.01 × 10−3 2.87 × 10−3 2.85 × 10−3 3.03 × 10−3 2.90 × 10−3 2.85 × 10−3 0.757

Statistical analysis for body weight using Kruskal-Wallis test as post hoc test. ∗∗ p < 0.05 using one-way ANOVA analysis. # p < 0.05 compared with control (—) using Tukey's test as post hoc test.

BW: body weight; LVW: left ventricular weight; RVW: right ventricular weight; AW: atrial weight; OVX 5: 5-week ovariectomy; OVX 9: 9-week ovariectomy; Treatments I, II, and III: 9-week ovariectomy with 500, 1500, and 2500 mg/kgBW ceplukan leaf's methanolic extract, respectively.